Trial: 201506113

A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients with Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Phase

I

Principal Investigator

Gillanders, William

Disease Site

Breast

Learn more about this study at: clinicaltrials.gov